Annual Drug Patent Expirations for BOSULIF
Bosulif is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for BOSULIF.
This drug has sixty-eight patent family members in thirty countries.
The generic ingredient in BOSULIF is bosutinib monohydrate. Two suppliers are listed for this compound. Additional details are available on the bosutinib monohydrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
